Remove 2006 Remove FDA Remove Packaging
article thumbnail

Securing every dose with an edible security technology for safe medicines

European Pharmaceutical Review

On- or in-dose authentication means that a security measure or anticounterfeit feature is integrated with the dosage form itself, offering product verification and traceability embedded into each medicine, rather than on the secondary package” WHO estimates that >50 percent of the drugs for sale on the internet are fake. References.

article thumbnail

Solving the taxing problems of taxanes?

European Pharmaceutical Review

Based on these results, Athenex filed for a new drug application (NDA) with the US Food and Drug Administration (FDA), but in early 2021 the company received a Complete Response Letter from FDA, citing various concerns including an “increase in neutropenia-related sequelae” in the Oraxol arm. References. Hennenfent K, Govindan R.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Sudafed Dosage, Uses, and Side Effects

BuzzRx

Keeping Sudafed products behind the counter, along with other regulations, was mandated by the FDA in 2006 because pseudoephedrine, the main ingredient in Sudafed products, can be used illegally to make methamphetamine. Read the package label carefully to check the right product and dosage for your child.

Dosage 52
article thumbnail

A Proposal for a Comprehensive Quality Overall Summary

ISPE

As part of the US Food and Drug Administration (FDA) QbD pilot 4 in 2005–2006, the need to convey how the control strategy is linked to the target product profile (TPP) and quality target product profile (QTPP) was discussed. Direct feedback from the US FDA on this pilot is shared in the discussion.

article thumbnail

A Proposal for a Comprehensive Quality Overall Summary

ISPE

As part of the US Food and Drug Administration (FDA) QbD pilot 4 in 2005–2006, the need to convey how the control strategy is linked to the target product profile (TPP) and quality target product profile (QTPP) was discussed. Direct feedback from the US FDA on this pilot is shared in the discussion.

article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

4 , 5 Additionally, reducing shipping limitations—such as packaging, storage, and transportation durations—helps speed up patient access in certain instances while ensuring there is no negative impact to the product’s critical quality attributes (CQAs). FDA Official Warns Manufacturers of Common Problems Found in Aseptic Operations.”

article thumbnail

Exclusive Coverage: Global PHT Expo & Summit 2023

PharmaShots

Manan Sharma- “as from the technology side I will start with the recently used cases like the government of India has already made it mandatory for around 300 drugs to have their barcode on the packaging to track and trace the information of the drugs. class that received its FDA approval in Oct’2006 for T2D.